Latest Articles in quarterly results
IOL Chemicals & Pharmaceuticals Net Profit Slumps By 40% YoY In Q3FY23
IOL Chemicals and Pharmaceuticals reported its net profits for the quarter at Rs 24 crores against Rs 40 crores recorded in the same quarter last year, a decline of 40 per cent year on year. IOL's EBITDA came at Rs 50 crore versus Rs 68 crore recorded in the December quarter last year
Read More
Q3 Results: Cipla's Net Profit Rises By10%, Consolidated Revenue At 5,810 Cr
Cipla's net profit also jumped by 10 per cent Year on Year in Q3FY22, the company recorded a net profit of Rs 801 crores in the December quarter. The company saw an increase of Rs 73 crores from the earnings of the same quarter last year which stood at Rs 728 crores
Read More
IOL Chemicals & Pharma's Stocks Tumble After PAT Slips By 55% QoQ In Q2FY23
IOL Chemicals and Pharmaceuticals net profits for Q2FY23 were recorded at Rs 15.6 crores against Rs 34.9 crores in Q1FY23, a dip of 55 per cent QoQ
Read More
Biocon's Net Profit Dips 10% YoY, Revenue At Rs 2,384 Cr In Q2FY23
Biocon registered a net profit of Rs 168 crores in the second quarter against Rs 188 crores registered in the corresponding quarter of the last year, a slump of 10 per cent year on year
Read More
JB Chemicals & Pharma's Net Profit Rises By 13% YoY, Revenue At Rs 809 Cr
JB Chemicals & Pharma recorded revenue of Rs 809 crores as compared to Rs 593 crores recorded in the same quarter last year, registering growth of 36 per cent
Read More
Q2 Results: Piramal Pharma Registers Loss Of Rs 37 Cr, EBITDA Rises By 2.2%
Piramal Pharma, an Indian pharmaceuticals company, today announced its consolidated results for the Second Quarter and Half Year ended 30th September 2022. The pharma company in the second quarter has reported a net loss of Rs 37 crores in its first quarterly results after getting listed on BSE
Read More
Q2 Results: Cipla Registers 5.7% Rise In Revenue, Reports PAT At Rs 789 Cr
The pharmaceutical company’s net profit also jumped by 10.91 per cent quarter on quarter in Q2FY22, the company recorded a net profit of Rs 788.90 crores in the September quarter
Read More
Rainbow Hospitals Reports 32% Rise In Sales In Sept Quarter, PAT Recorded At 61.5 Cr
EBITDA earnings for Q2FY23 of the hospital also soared with a quarter-on-quarter increase of 34.99 per cent and stood at Rs 109.5 crores up from Rs 89.2 crores in the second quarter last year
Read More
Q2 Results: Max Healthcare Registers 147% YoY Growth In Net Profit At Rs 511 Cr
Net profit for the September quarter stood at Rs 511 Cr compared to INR 207 Cr in the second quarter last year and Rs 229 Cr in Q1 FY23
Read More
Q2 Results: Sun Pharma Sales Up By 10% YoY, Records Net Profit Of 2,262 Cr
The company’s sales in India were recorded at Rs 3,460 crore, a rise of 8.5 per cent against the second quarter of last year. At the same time, the sales in the US were up by 27.5 per cent quarter on quarter and stood at USD 200 million
Read More